Hangzhou Biotest Biotech Co Ltd (688767) — Financial Flexibility Index
Hangzhou Biotest Biotech Co Ltd (688767) has a Financial Flexibility Index of 0.56x as of September 2025. Free cash flow of CN¥75.41 Million (operating CF CN¥28.39 Million minus capex CN¥47.02 Million) represents 1% of total liabilities (CN¥134.75 Million). Also explore Hangzhou Biotest Biotech Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hangzhou Biotest Biotech Co Ltd Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Hangzhou Biotest Biotech Co Ltd across 9 annual periods. Check Hangzhou Biotest Biotech Co Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Hangzhou Biotest Biotech Co Ltd (2017–2025)
Year-by-year free cash flow to debt coverage for Hangzhou Biotest Biotech Co Ltd. For the full company profile including market capitalisation, see Hangzhou Biotest Biotech Co Ltd market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.41x | CN¥236.34 Million | CN¥106.47 Million | CN¥168.17 Million | ▼ -28.7% |
| 2024 | 1.97x | CN¥373.88 Million | CN¥128.83 Million | CN¥189.79 Million | ▲ +66.6% |
| 2023 | 1.18x | CN¥187.80 Million | CN¥131.38 Million | CN¥158.82 Million | ▼ -74.7% |
| 2022 | 4.67x | CN¥882.13 Million | CN¥703.21 Million | CN¥188.92 Million | ▲ +36.2% |
| 2021 | 3.43x | CN¥1.11 Billion | CN¥908.12 Million | CN¥323.36 Million | ▲ +29.9% |
| 2020 | 2.64x | CN¥503.75 Million | CN¥446.07 Million | CN¥190.89 Million | ▲ +242.3% |
| 2019 | 0.77x | CN¥65.14 Million | CN¥25.67 Million | CN¥84.50 Million | ▲ +28.7% |
| 2018 | 0.60x | CN¥33.84 Million | CN¥21.17 Million | CN¥56.48 Million | ▼ -14.2% |
| 2017 | 0.70x | CN¥33.44 Million | CN¥7.07 Million | CN¥47.88 Million | — |